BeStock  
Stocks › Biotechnology › SLN

Silence Therapeutics SLN

US equityMarket cap rank #3022Biotechnology
$19.81 +$0.00 (0.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $19.81 0.00%
Open$19.81
Prev close$19.81
Day range$19.80 – $19.83
Volume399.1K
Market cap$1.23B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusHold
Analysts4
Average target$20.00+1.0% vs. price
  • Hold 100%

Recent rating changes

The last 20 actions on file set price targets from $4.00 to $75.00, averaging $37.86.

DateFirmRatingTarget
21 Oct 2026 H.C. Wainwright HOLD $20.00
19 Oct 2026 Chardan Capital HOLD $20.00
19 Oct 2026 William Blair HOLD –
19 Oct 2026 Jefferies HOLD $20.00
21 Sep 2026 H.C. Wainwright BUY $75.00
10 Sep 2026 William Blair BUY –
16 Aug 2026 Chardan Capital BUY –
14 Aug 2026 H.C. Wainwright BUY $75.00
11 Aug 2026 Morgan Stanley BUY $32.00
11 Aug 2026 H.C. Wainwright BUY $75.00
10 Aug 2026 Chardan Capital BUY $27.00
10 Aug 2026 William Blair BUY –
10 Aug 2026 Morgan Stanley BUY $32.00
10 Aug 2026 H.C. Wainwright BUY $75.00
27 Jul 2026 Goldman Sachs SELL $4.00
24 Jun 2026 Cantor Fitzgerald BUY –
11 Jun 2026 William Blair BUY –
11 Jun 2026 Morgan Stanley BUY $25.00
2 Jun 2026 Morgan Stanley BUY $25.00
29 May 2026 Morgan Stanley BUY $25.00

Discussion

No comments yet — be the first to weigh in on SLN.

Sign in to join the discussion.

Scroll to Top